FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40455811000001109: Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Feb 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1940281000001119 Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1940291000001117 Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route powderinhalation.inhalation ontology form and route true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Inhalation true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Is a Product containing fluticasone and salmeterol false Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Is a Fluticasone + Salmeterol true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler 60 dose Has VMP True Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier
Seffalair Spiromax 12.75micrograms/dose / 202micrograms/dose dry powder inhaler (Teva UK Ltd) Is a True Fluticasone propionate 202micrograms/dose / Salmeterol 12.75micrograms/dose dry powder inhaler Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start